Using ovalbumin-loaded cDC1s (Ova DCs) and established Kras;Trp53 (KP) Ova cell tumors, we measured the impact of each preconditioning regimen on tumor growth, survival, and the magnitude of antigen-specific CD8+ T cell responses. Here, CD8A is linked to neoplasm.